Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
09/2004
09/29/2004CN1168439C Drug delivery device, especially for delivery of progestins and estrogens
09/28/2004US6797709 Sexual disorders
09/28/2004US6797259 Delivery of muscle relaxants through an inhalation route
09/28/2004CA2299013C Neuropeptide y antagonists
09/23/2004WO2004080985A1 3-(1-[3-(1,3-benzothiazol-6-yl)propylcarbamoyl]cycloalkyl)propanoic acid derivatives as nep inhibitors
09/23/2004WO2004080968A1 6-substituted nicotinamide derivatives as opioid receptor antagonists
09/23/2004WO2004080479A1 Gonadal function improving agents
09/23/2004WO2004080442A1 Extended transdermal contraceptive regimens
09/23/2004WO2004058269A9 Use of gnrh agonists to support the luteal phase during infertility treatment
09/23/2004WO2004052365A3 Inhibition of inflamation using alpha 7 receptor-binding cholinergic agonists
09/23/2004WO2003011219A3 Mediators of hedgehog signaling pathways, compositions and uses related thereto
09/23/2004US20040186178 Amidino compounds useful as nitric oxide synthase inhibitors
09/23/2004US20040186163 Novel combination
09/23/2004US20040186157 inhibiting kinases; for treating or preventing neoplasia, rheumatoid arthritis, pulmonary fibrosis, myelofibrosis, abnormal wound healing, atherosclerosis, or restenosis, alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, stroke, ischaemia, Huntington's disease, AIDS dementia
09/23/2004US20040186145 Sulfur substituted sulfonylaminocarboxylic acid N-arylamides, their preparation, their use and pharmaceutical preparations comprising them
09/23/2004US20040186130 Delivery of muscle relaxants through an inhalation route
09/23/2004US20040186126 Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use
09/23/2004US20040186113 Heterocyclic amines for the treatment of conditions associated with gsk-3
09/23/2004US20040186101 such as 6-(3-Chlorophenyl)-4,4-dimethyl-1,4-dihydrobenzo[d][1,3]oxazin-2-one; hormone replacement therapy
09/23/2004US20040186086 Estetrol and estetrol-like substances have relatively low estrogenic potency, metabolic stability, long half-life; triene steroids
09/23/2004US20040185065 Warming and nonirritating lubricant compositions and method of comparing irritation
09/23/2004US20040185008 Delivery of compounds for the treatment of parkinsons through an inhalation route
09/23/2004US20040185007 heating layers containing drugs such as benztropine, pergolide, ropinirole, amantadine and deprenyl on solid supports, to produce vapors, then condensing to aerosols which can be delivered by breathing; drug delivery method and devices
09/23/2004US20040185006 Delivery of stimulants through an inhalation route
09/23/2004US20040185005 Condensation aerosol as doage forms, is produced by heating a thin layer containing of dolasetron, granisetron or metoclopramide to form vapor, condense into an aerosol; fast producing peak plasma concentrations
09/23/2004US20040185004 Delivery of erectile dysfunction drugs through an inhalation route
09/23/2004US20040185002 condensation aerosol for delivery of a drug selected from chlordiazepoxide, betahistine, clonidine, testosterone, a conjugated estrogen, an estrogen ester, estradiol, an estradiol ester, ethinyl estradiol, an ethinyl estradiol ester and hyoscyamine
09/23/2004US20040185001 Delivery of physiologically active compounds through an inhalation route
09/23/2004US20040185000 Delivery of antihistamines through an inhalation route
09/23/2004US20040184999 Delivery of anti-migraine compounds through an inhalation route
09/23/2004US20040184998 Delivery of drug esters through an inhalation route
09/23/2004US20040184997 volatilizing a coating of drug on a solid support, having the surface texture of a metal foil, to a temperature sufficient to produce a heated vapor of drug and condensing the heated vapor to form condensation aerosol particles
09/23/2004US20040184996 Delivery of nonsteroidal antiinflammatory drugs through an inhalation route
09/23/2004CA2519072A1 3-(1-[3-(1,3-benzothiazol-6-yl)propylcarbamoyl]cycloalkyl)propanoic acid derivatives as nep inhibitors
09/23/2004CA2518541A1 Gonadal function improving agents
09/23/2004CA2518194A1 6-substituted nicotinamide derivatives as opioid receptor antagonists
09/23/2004CA2517778A1 Extended transdermal contraceptive regimens
09/22/2004EP1460077A1 Novel pyrazolopyrimidones and their use as PDE inhibitors
09/22/2004EP1460074A1 Substituted amino alkyl compounds
09/22/2004EP1460073A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
09/22/2004EP1460070A1 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
09/22/2004EP1460069A1 Substituted cyclohexyl and piperidinyl derivatives as melanocortin-4 receptor modulators
09/22/2004EP1460062A1 Nitrogenous cyclic ketone derivative, process for producing the same, and use
09/22/2004EP1458754A2 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control
09/22/2004EP1458723A1 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function
09/22/2004EP1458722A1 Pyrrolopyrimidines as phosphodiesterase vii inhibitors
09/22/2004EP1458718A1 Quinolinones as prostaglandin receptor ligands
09/22/2004EP1458714A1 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives
09/22/2004EP1458711A1 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer s disease and conditions associated with glycogen synthase kinase-3
09/22/2004EP1458707A2 New compounds
09/22/2004EP1458706A1 Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor
09/22/2004EP1458690A1 5,6-diaryl-pyrazine-2-amide derivatives as cb1 antagonists
09/22/2004EP1458679A2 Pyrrolidine derivatives as prostaglandin modulators
09/22/2004EP1458401A1 Composition comprising dextrinsulfate for the treatment of sexual transmitted diseases (std)
09/22/2004EP1458399A1 Pregnane steroids for use in the treatment of cns disorders
09/22/2004EP1458395A1 New use
09/22/2004EP1458394A1 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer s disease and conditions associated with glycogen synthase kinase-3
09/22/2004EP1458393A1 Substituted diketopiperazines as oxytocin antagonists
09/22/2004EP1458389A1 Use of moxaverin for treating erectile dysfunction, forms of dementia or diseases associated to an arteriosclerotic occlusion
09/22/2004EP1458381A1 Triazoles as oxytocin antagonists
09/22/2004EP1458363A1 Pre-formulation for the tabletting of natural mixtures of conjugated estrogens
09/22/2004EP1196428B1 11-beta-aryl-17,17-spirothiolane-substituted steroids
09/22/2004EP1192165B1 Substituted heterocycle fused gamma-carbolines
09/22/2004EP1189904B1 Substituted heterocycle fused gamma-carbolines
09/22/2004EP1140160B1 Method for producing autogenous vaccines for treating chlamydial infections in mammals and humans
09/22/2004EP1124801B1 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress
09/22/2004EP1100503B1 Non-imidazole alkylamines as histamine h 3?-receptor ligands and their therapeutic applications
09/22/2004EP0623133B1 Substituted amino alkyl compounds
09/22/2004CN1531653A Method for identification of proteins from intracellular bacteria
09/22/2004CN1531546A Peptide compounds
09/22/2004CN1531537A Novel tricyclic pyridyl benzazepine carboxyamides and derivatives their tocolytic oxytocin leceptor antagonists
09/22/2004CN1531536A Process for preparation of pyrazolo[4,3-D] pyrimidine derivative
09/22/2004CN1531441A Pharmaceutical compositinos which inhibit vascular proliferation and method of use thereof
09/22/2004CN1531434A Selective dopamine D4 receptor agonists for treating sexual dysfuction
09/22/2004CN1531420A Pharmaceutical formulation for efficient administration of apomorphine, 6aR-(-)-N-propyl-norepomorphine and their derivatives and pro-drugs thereof
09/22/2004CN1530440A Monocolone antibody, encoding gene, its uses and hybrid nodule cell line for cecreting same
09/22/2004CN1530366A Sulphonic acid amide for regulating bast peptide activity and derivative thereof
09/22/2004CN1530126A Medicine composition, preparing method and use for preparing gynacecopathia medicine
09/22/2004CN1530125A Medicie composition, preparing method and use for preparing gynaecopathia medicine
09/22/2004CN1530118A Tonifying Yang wine
09/22/2004CN1167692C Aminothiazole derivatives and their use as CRF receptor ligands
09/22/2004CN1167670C Aryl carboxylic acid and tetrazole derivant
09/22/2004CN1167464C Medicine for artificially inducing rockfish's sex reversion and its preparation
09/22/2004CN1167463C Preparation of medicines for diseases in peripheral nerve system and male genetic defects
09/22/2004CN1167446C Chinese medicinal gel for cervicitis and cervical erosion, and preparation thereof
09/22/2004CN1167435C Chinese medicine for treating male veneral diseases
09/22/2004CN1167431C Chinese medicine plaster for treating mastoproliferation and its preparation
09/22/2004CN1167427C Preparing method of life prolonging preparation
09/21/2004US6795776 Crystallographic structure of the androgen receptor ligand binding domain
09/21/2004US6794512 Antiinflammatory agents; cyclooxygenase inhbitors; anticancer agents; autoimmune disease
09/21/2004US6794489 Peptide sequence ac-nle-cyclo(-asp-his-d-phe-arg-trp-lys)-oh derived from a melanocyte-stimulating hormone (? alpha -msh?) analog, called melanotan-ii
09/21/2004US6794403 Substituted benzoxazoles as estrogenic agents
09/21/2004US6794397 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof
09/21/2004US6794387 Pharmaceutically active compounds
09/21/2004US6794373 Contraceptive methods using benzimidazolones
09/21/2004US6793923 Vaccines with enhanced immune response and methods for their preparation
09/16/2004WO2004078717A1 Acylated piperazine derivatives as melanocortin-4 receptor agonists
09/16/2004WO2004078716A1 Acylated piperazine derivatives as melanocortin-4 receptor agonists
09/16/2004WO2004050679A3 Mutant glycoproteins
09/16/2004WO2003104253A3 9-alpha-substituted estratrienes as selectively active estrogen